Evaluate for Akathisia and Extrapyramidal Side Effects
A patient on risperidone who reports feeling tense is most likely experiencing akathisia, a common extrapyramidal side effect that risperidone causes more frequently than other atypical antipsychotics. This requires immediate assessment and management to prevent medication discontinuation and maintain treatment adherence.
Initial Assessment
Determine if this represents akathisia (subjective restlessness) versus other causes:
- Timing: Akathisia typically occurs within the first few days of starting risperidone or after dose increases 1
- Characteristics: Ask specifically about inner restlessness, inability to sit still, pacing, or leg movements
- Dose relationship: Among atypical antipsychotics, risperidone is the most likely to produce extrapyramidal side effects 2
Key distinction: The feeling of "tension" with akathisia is motor-driven restlessness, not anxiety or psychotic agitation. Patients often describe it as needing to move constantly.
Check Current Risperidone Dose
Review if the dose is appropriate:
- Adults with schizophrenia: Effective range 2-8 mg/day 3
- First-episode psychosis: Should use lower doses (2 mg/day risperidone) 4
- Higher doses increase EPS risk: The relationship is dose-dependent 2
Immediate Management Options
Option 1: Dose Reduction (Preferred First Step)
Reduce the risperidone dose if clinically feasible without compromising psychotic symptom control 1. This is the safest approach that addresses the root cause.
Option 2: Add Anticholinergic Agent
If dose reduction isn't possible due to inadequate symptom control, add an anticholinergic medication (e.g., benztropine, diphenhydramine) 1. However, be aware this adds medication burden and anticholinergic side effects.
Option 3: Switch to Lower-EPS Atypical Antipsychotic
Consider switching to olanzapine, quetiapine, or aripiprazole, which have lower rates of extrapyramidal symptoms 2. Switching should follow proper cross-titration protocols to avoid withdrawal symptoms 5.
Critical Pitfalls to Avoid
Do not mistake akathisia for worsening psychosis or anxiety and increase the antipsychotic dose—this will worsen the problem 1. One study found that some patients with schizophrenia on risperidone developed "intolerable affect" including agitation that was actually a medication side effect, not disease progression 6.
Do not abruptly discontinue risperidone without proper tapering, as this can cause withdrawal symptoms including rebound psychosis, insomnia, nausea, and agitation 5.
Rule Out Other Causes
Before attributing tension solely to akathisia, briefly assess:
- Worsening psychosis: Are positive symptoms increasing?
- Anxiety disorder: Was anxiety present before risperidone?
- Drug-induced Parkinsonism: Look for rigidity, bradykinesia, tremor 1
- Increased affect syndrome: Some patients experience heightened emotional reactivity on risperidone, particularly those with baseline anxiety 6
Monitoring After Intervention
- Reassess symptoms within 24-48 hours of any dose adjustment
- If akathisia persists despite intervention, switching antipsychotics is warranted 1
- Document the response to guide future medication decisions
The evidence strongly supports that risperidone has the highest EPS risk among atypical antipsychotics 2, making akathisia a predictable and manageable adverse effect when recognized early.